Latest News and Press Releases

ST. LOUIS, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that...

Continued progress on strategic innovation initiatives; expect to showcase in 1H 20194% recurring revenue growth; reaffirming 2018 record recurring revenue expectationsConference call today at 10:00...

ST. LOUIS, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it...

ST. LOUIS, Mo., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced...

Progress on strategic internal innovation and external collaborationsContinued growth in recurring revenuePositive cash flow from operationsReaffirming 2018 expectationsConference call today at 10:00...

ST. LOUIS, July 31, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it...

ST. LOUIS, June 25, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that it...

ST. LOUIS, June 04, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the...

ST. LOUIS, May 22, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...

3% year-over-year growth in recurring revenueContinued progress on strategic innovation initiatives; collaboration with Acutus MedicalIncreasing quantity and quality of peer-reviewed clinical...